If, when and how does an investment in IP pay off? You will receive answers to these questions from our partners Dr. Christiane Maxien and Dr. Christian Kirchner in the current issue of Plattform Life Sciences.
It always starts with the idea of improving the health of the individual through personalized medical technology. If this succeeds, sooner or later the questions will arise: How can I protect this idea - is it also patentable? This topic is often relevant for many, especially when it comes to data-based innovations....
The mission of the Life Sciences platform from the GoingPublic publishing house is the cross-media connection (magazine - web - event - network) of the life sciences with knowledge and networks from corporate finance and the capital market. According to its own statements, GoingPublic Media AG is one of the leading media houses for corporate financing and investment issues. As part of its cross-media platform approach, the group publishes around 40 magazine issues per year and operates three web platforms, including the Life Sciences platform, in connection with online newsletters and social media presences.
Read the article (in German) here.
Here is the link to the complete e-magazine: https://www.goingpublic.de/aktuelles-epaper-lifesciences/
